Related Experiment Video
Updated: Nov 20, 2025

Construction of Homozygous Mutants of Migratory Locust Using CRISPR/Cas9 Technology
Published on: March 16, 2022
CRISPR/dCas9-mediated transposition with specificity and efficiency of site-directed genomic insertions
Lena Goshayeshi1,2, Sara Yousefi Taemeh1,2, Nima Dehdilani1,2
1Division of Biotechnology, Faculty of Veterinary Medicine, Ferdowsi University of Mashhad, Mashhad, Iran.
Abstract:
The ability and efficiency of targeted nucleases to perform sequence replacements or insertions into the genome are limited. This limited efficiency for sequence replacements or insertions can be explained by the dependency on DNA repair pathways, the possibility of cellular toxicity, and unwanted activation of proto-oncogenes. The piggyBac (PB) transposase uses a very efficient enzymatic mechanism to integrate DNA fragments into the genome in a random manner. In this study, we fused an RNA-guided catalytically inactive Cas9 (dCas9) to the PB transposase and used dual sgRNAs to localize this molecule to specific genomic targets. We designed and used a promoter/reporter complementation assay to register and recover cells harboring-specific integrations, where only by complementation upon correct genomic integration, the reporter can be activated. Using an RNA-guided piggyBac transposase and dual sgRNAs, we were able to achieve site-directed integrations in the human ROSA26 safe harbor region in 0.32% of cells. These findings show that the methodology used in this study can be used for targeting genomic regions. An application for this finding could be in cancer cells to insert sequences into specific target regions that are intended to be destroyed, or to place promoter cargos behind the tumor suppressor genes to activate them.
Insights
Researchers developed a novel RNA-guided piggyBac transposase system for precise DNA integration. This method overcomes limitations of traditional gene editing, enabling targeted genomic insertions with potential applications in cancer therapy.
Area of Science:
- Molecular Biology
- Genetics
- Biotechnology
Background:
- Current targeted nucleases for genome editing have limited efficiency for sequence replacements or insertions.
- Limitations include reliance on DNA repair pathways, potential cellular toxicity, and proto-oncogene activation.
- The piggyBac (PB) transposase offers efficient, albeit random, DNA integration into the genome.
Purpose of the Study:
- To develop a method for site-directed DNA integration using a fusion of catalytically inactive Cas9 (dCas9) and PB transposase.
- To enhance precision and efficiency in genomic insertions by guiding the PB transposase to specific DNA targets.
- To establish a system for recovering cells with successful targeted integrations.
Main Methods:
- Fused catalytically inactive Cas9 (dCas9) to the piggyBac (PB) transposase.
- Utilized dual single-guide RNAs (sgRNAs) to direct the dCas9-PB fusion to specific genomic locations.
- Employed a promoter/reporter complementation assay to identify and select cells with accurate genomic integrations.
Main Results:
- Achieved site-directed integrations into the human ROSA26 safe harbor region using the RNA-guided PB transposase system.
- Demonstrated successful targeting with an efficiency of 0.32% of cells.
- Validated the functionality of the promoter/reporter complementation assay for detecting specific integrations.
Conclusions:
- The developed RNA-guided piggyBac transposase methodology enables precise targeting of specific genomic regions.
- This approach offers a potential solution to the limitations of existing gene editing technologies.
- Potential applications include targeted sequence insertion in cancer cells for therapeutic purposes, such as activating tumor suppressor genes or inserting sequences for destruction.
Related Concept Videos
CRISPR/Cas9 Genome Editing
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...
CRISPR
Homologous Recombination
DNA-only Transposons
The donor site from where the transposon is excised is either degraded or...
CRISPR and crRNAs
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...

